Skip to main content

Table 2 Top 15 potential targets in the PC-PT network according to degree and betweenness centrality

From: Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology

Protein Name

Degree

Betweenness Centrality

Protein Name

Degree

Betweenness Centrality

PTGS2

54

0.277312173

PTGS2

54

0.277312173

ESR1

46

0.153120648

PTGS1

42

0.204507204

PTGS1

42

0.204507204

ESR1

46

0.153120648

NOS2

19

0.032615148

CXCR4

8

0.086469588

AKT1

15

0.01512124

TNF

12

0.060803175

GSK3B

13

0.009859331

CYP3A4

12

0.058290209

CYP3A4

12

0.058290209

HMOX1

6

0.035902065

TNF

12

0.060803175

HIF1A

4

0.035245261

ACTB

10

0.013813159

ICAM1

5

0.034843635

MAPK14

10

0.001209612

NOS2

19

0.032615148

CEBPB

9

0.007230542

IL1B

8

0.031406599

ANXA1

8

0.014493758

TGFBR2

4

0.029023858

CXCR4

8

0.086469588

IFNG

4

0.016903104

IL1B

8

0.031406599

AKT1

15

0.01512124

IL6

6

0.009704189

SERPINE1

5

0.014896122